In breast cancer, CD24−/CD44+ mesenchymal CSCs are typically located toward the invasive edge of the tumor by the tumor-stroma interface, while ALDH1+ CSCs are found in the more interior region [152]. Here, ALDH1A1 is linked to neoplasm.